Doppler effect

NTI 2024: Flosonics Medical Presents Educational Dinner Symposium on the Future of Sepsis Resuscitation

Retrieved on: 
Freitag, Mai 17, 2024

Toronto, Canada, May 17, 2024 (GLOBE NEWSWIRE) -- Flosonics Medical, a leader in wearable medical ultrasound, announced it will be demonstrating its FloPatch solution at the American Association of Critical-Care Nurses’ annual conference, the National Teaching Institute & Critical Care Exposition 2024 (NTI) in Denver, May 21-22.

Key Points: 
  • Toronto, Canada, May 17, 2024 (GLOBE NEWSWIRE) -- Flosonics Medical, a leader in wearable medical ultrasound, announced it will be demonstrating its FloPatch solution at the American Association of Critical-Care Nurses’ annual conference, the National Teaching Institute & Critical Care Exposition 2024 (NTI) in Denver, May 21-22.
  • NTI attendees are invited to attend a free In-Person and Virtual Dinner Symposium: “The Future of Sepsis Resuscitation,” hosted by Flosonics, on the evening of Tuesday, May 21.
  • Visit Flosonics at NTI in Booth #1543 for a hands-on FloPatch experience featuring expert engagement and live demonstrations.
  • Also, don't miss the opportunity to win a FREE iPad by visiting our booth.

$3.8 Bn Portable Ultrasound Market - Global Forecast to 2031: Emerging Economies and Increasing Preference for PoC Testing to Provide Opportunities - ResearchAndMarkets.com

Retrieved on: 
Dienstag, April 23, 2024

The portable ultrasound market is expected to reach $3.8 billion by 2030, at a CAGR of 7.9% from 2024 to 2031.

Key Points: 
  • The portable ultrasound market is expected to reach $3.8 billion by 2030, at a CAGR of 7.9% from 2024 to 2031.
  • The growing preference for portable ultrasound devices over standard ultrasound machines among healthcare professionals is expected to create growth opportunities for players operating in this market.
  • Based on display, the portable ultrasound devices are further segmented into color ultrasound and black & white (B/W) ultrasound.
  • In 2024, the hospitals & clinics segment is expected to account for the largest share of the global portable ultrasound market.

EchoNous Announces Revolutionary AI Enhancements in Upcoming Kosmos Release for Apple iOS

Retrieved on: 
Freitag, April 5, 2024

REDMOND, Wash., April 05, 2024 (GLOBE NEWSWIRE) -- EchoNous, a leading innovator in ultrasound technology, is thrilled to announce the upcoming Kosmos 2.2 release on Apple iOS, a monumental update enriched with powerful new automated enhancements and significant workflow improvements, setting a new standard in point-of-care (POCUS) imaging.

Key Points: 
  • REDMOND, Wash., April 05, 2024 (GLOBE NEWSWIRE) -- EchoNous, a leading innovator in ultrasound technology, is thrilled to announce the upcoming Kosmos 2.2 release on Apple iOS, a monumental update enriched with powerful new automated enhancements and significant workflow improvements, setting a new standard in point-of-care (POCUS) imaging.
  • This feature is especially beneficial for new users, ensuring that they operate under the preset that will give them optimal image clarity.
  • These AI-driven features exemplify EchoNous’ commitment to enhancing user control while streamlining procedures, allowing for uninterrupted scanning and optimal imaging results.
  • EchoNous is excited to showcase these groundbreaking features at ACC and forthcoming shows such as AIUM, ACP, SHM, and ASE in the weeks ahead.

Flosonics Medical Secures $20 Million USD in Series C Funding Led by New Leaf Venture Partners to Accelerate Growth

Retrieved on: 
Dienstag, März 19, 2024

Flosonics Medical, a leader in wearable medical ultrasound, today announced its Series C financing, raising $20 million USD.

Key Points: 
  • Flosonics Medical, a leader in wearable medical ultrasound, today announced its Series C financing, raising $20 million USD.
  • The round was led by New Leaf Venture Partners, with participation from previous investors Arboretum Ventures, Genesys Capital, and iGan Partners.
  • “We are thrilled to have New Leaf Venture Partners lead our Series C round and welcome Vijay Lathi to our board,” said Joe Eibl, CEO of Flosonics Medical.
  • About New Leaf Venture Partners: New Leaf Venture Partners is a leader in healthcare technology venture investing.

Military Transmit and Receive Module Market worth $7.7 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Donnerstag, Dezember 21, 2023

The gallium nitride segment is projected to grow at the highest CAGR rate for the military transmit and receive module market during the forecast period.

Key Points: 
  • The gallium nitride segment is projected to grow at the highest CAGR rate for the military transmit and receive module market during the forecast period.
  • By platform, the airborne segment is estimated to account for the largest market share of the Military transmit and receive module market in 2023.
  • The airborne segment is estimated to account for the largest share of 42% of the military transmit and receive module market in 2023.
  • The North American market is going to contribute the largest share of 36% to the military transmit and receive module industry in 2023.

Military Transmit and Receive Module Market worth $7.7 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Donnerstag, Dezember 21, 2023

The gallium nitride segment is projected to grow at the highest CAGR rate for the military transmit and receive module market during the forecast period.

Key Points: 
  • The gallium nitride segment is projected to grow at the highest CAGR rate for the military transmit and receive module market during the forecast period.
  • By platform, the airborne segment is estimated to account for the largest market share of the Military transmit and receive module market in 2023.
  • The airborne segment is estimated to account for the largest share of 42% of the military transmit and receive module market in 2023.
  • The North American market is going to contribute the largest share of 36% to the military transmit and receive module industry in 2023.

Marine Onboard Communication and Control Systems Market worth $12.3 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Montag, Dezember 18, 2023

The marine control systems market is driven by vessel modernization efforts; the need for enhanced efficiency and safety propels the adoption of various control systems for propulsion, navigation, and automation.

Key Points: 
  • The marine control systems market is driven by vessel modernization efforts; the need for enhanced efficiency and safety propels the adoption of various control systems for propulsion, navigation, and automation.
  • The Marine Onboard Communication and Control Systems market encompasses a type, platform, and end-user that leverages these benefits.
  • Based on the type, the control systems segment is estimated to lead the Marine Onboard Communication and Control Systems industry from 2023 to 2028.
  • To meet the regulatory compliance the navies are adopting various propulsion control systems, engine control and monitoring systems which drive the marine control systems market.

Marine Onboard Communication and Control Systems Market worth $12.3 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Montag, Dezember 18, 2023

The marine control systems market is driven by vessel modernization efforts; the need for enhanced efficiency and safety propels the adoption of various control systems for propulsion, navigation, and automation.

Key Points: 
  • The marine control systems market is driven by vessel modernization efforts; the need for enhanced efficiency and safety propels the adoption of various control systems for propulsion, navigation, and automation.
  • The Marine Onboard Communication and Control Systems market encompasses a type, platform, and end-user that leverages these benefits.
  • Based on the type, the control systems segment is estimated to lead the Marine Onboard Communication and Control Systems industry from 2023 to 2028.
  • To meet the regulatory compliance the navies are adopting various propulsion control systems, engine control and monitoring systems which drive the marine control systems market.

Baraja announces availability of integrated components for new-to-world Doppler RMCW Spectrum-Scan™ LiDAR

Retrieved on: 
Mittwoch, November 29, 2023

PALO ALTO, Calif., Nov. 29, 2023 /PRNewswire/ -- Baraja , creator of the breakthrough Spectrum-Scan™ LiDAR technology, announces the availability of A-Samples of all the integrated components necessary to build a new-to-world Doppler RMCW Spectrum-Scan™ LiDAR for automotive integration.

Key Points: 
  • PALO ALTO, Calif., Nov. 29, 2023 /PRNewswire/ -- Baraja , creator of the breakthrough Spectrum-Scan™ LiDAR technology, announces the availability of A-Samples of all the integrated components necessary to build a new-to-world Doppler RMCW Spectrum-Scan™ LiDAR for automotive integration.
  • "Multiple heterogeneous sub-systems are contained in a LiDAR, this would require each sub-system's integration via completely different classes of chips and using different processes.
  • The Bidirectional Optical Sub-Assembly (BOSA) integrates 3 types of chips in an automotive-grade, hermetically sealed and temperature controlled enclosure (3x3.5cm).
  • These chips are: the laser chip (InP), the homodyne receiver chip (silicon photonics) and the TIA chips (silicon).

First Round of Late-Breaking Clinical Trial Results Announced at VIVA23

Retrieved on: 
Dienstag, Oktober 31, 2023

Below are highlights of this morning's 5 late-breaking clinical trial presentations.

Key Points: 
  • Below are highlights of this morning's 5 late-breaking clinical trial presentations.
  • At 20 centers without roll-ins across the United States, 105 no-option CLTI patients were enrolled in a nonrandomized manner.
  • The median age was 70 years, two-thirds of the patients were male, and one-quarter of patients were Hispanic or Latino.
  • 1-Year Results of the DEEPER OUS Trial: The Bare Temporary Spur Stent System in Combination With a Paclitaxel-Coated Balloon
    The DEEPER OUS trial is a prospective, nonrandomized, multicenter, single-arm trial taking place in New Zealand, Germany, and Switzerland.